11 June 2022>: Clinical Research
Efficacy of Focused Extracorporeal Shock Wave Therapy in Chronic Low Back Pain: A Prospective Randomized 3-Month Follow-Up Study
Katarzyna Rajfur 1ABDEF , Joanna Rajfur 1ABDEF , Tomasz Matusz 1ABF , Karolina Walewicz 1ABD , Robert Dymarek 2ABDEFG* , Kuba Ptaszkowski 2ABCD , Jakub Taradaj 3ACDEFGDOI: 10.12659/MSM.936614
Med Sci Monit 2022; 28:e936614
Table 2 Characteristics of the study groups.
Variable | Experimental fESWT group | Control fESWT group | P value | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
χ̄ | Me | Min | Max | Q1 | Q3 | SD | χ̄ | Me | Min | Max | Q1 | Q3 | SD | ||
Age [years] | 4.3 | 43.0 | 18.0 | 64.0 | 33.0 | 49.0 | 13.1 | 45,4 | 49.0 | 22.0 | 76.0 | 36.0 | 55.0 | 14.0 | 0.490 |
Body weight [kg] | 72.8 | 73.0 | 57.0 | 90.0 | 61.0 | 83.0 | 11.6 | 74.5 | 77.0 | 55.0 | 87.0 | 72.0 | 81.0 | 9.2 | 0.989 |
Body height [cm] | 172.6 | 173.0 | 156,0 | 186.0 | 164.0 | 178.0 | 7.9 | 168.1 | 170.0 | 150.0 | 182.0 | 163.5 | 172.0 | 8.8 | 0.068 |
BMI [kg/m] | 24.3 | 23.6 | 18.3 | 30.5 | 21.8 | 27.8 | 3.9 | 26.5 | 27.1 | 22.0 | 32.0 | 24.3 | 27.8 | 3.0 | 0.102 |
Disease duration [months] | 57.5 | 48.0 | 3.0 | 204.0 | 24.0 | 84.0 | 50.9 | 61.8 | 60.0 | 3.0 | 180.0 | 24.0 | 72.0 | 53.1 | 0.989 |
Sex | F – n=10; 50.0%M – n=10; 50.0% | F – n=10; 50.0%M – n=10; 50.0% | 1.000 | ||||||||||||
fESWT – focused extracorporeal shock wave; n – number of individuals; χ̄ – mean; Me – median; Min – minimum value; Max – maximum value; Q1 – lower quartile; Q3 – upper quartile; SD – standard deviation; F – female; M – male. * U-Mann-Whitney; ** Chi-square test. |